Tri-I Biotech
Tri-I Biotech (源资信息科技（上海）有限公司) is a high-tech company founded in 2008 specializing in AI computing simulation and digital empowerment solutions for life sciences and materials science. The company provides comprehensive software solutions and consulting services covering bioinformatics, drug discovery, materials research, clinical trial design and data analysis, and enterprise quality information management. Tri-I Biotech offers AI-enriched computational simulation platforms such as quantum mechanics software, multi-scale simulation, molecular docking, pharmacokinetics/pharmacodynamics analysis, and clinical trial simulation. It also delivers GxP digital empowerment solutions including quality management systems, document management, pharmacovigilance, clinical data capture, and compliant electronic signature systems. The company serves over 300 well-known pharmaceutical and chemical enterprises, collaborates with more than 2000 academic and research institutions, and supports over 100 clinical research institutes and hospitals. With a nationwide service network centered in Shanghai and branches in Beijing, Chongqing, Taipei, and Hong Kong, Tri-I Biotech is recognized for its professional software and high-quality services, holding honors such as ISO9001 and ISO27001 certifications and titles for specialized and innovative enterprises in Shanghai. Its flagship products include the Simcyp Discovery simulator for early drug development decision support, and a broad portfolio of AI-driven platforms for drug discovery, materials design, and clinical research. The company also provides cloud computing services and AI technology services to empower scientific research and compliance in the life sciences industry.
Tri-I Biotech
Tri-I Biotech (源资信息科技（上海）有限公司) is a high-tech company founded in 2008 specializing in AI computing simulation and digital empowerment solutions for life sciences and materials science. The company provides comprehensive software solutions and consulting services covering bioinformatics, drug discovery, materials research, clinical trial design and data analysis, and enterprise quality information management. Tri-I Biotech offers AI-enriched computational simulation platforms such as quantum mechanics software, multi-scale simulation, molecular docking, pharmacokinetics/pharmacodynamics analysis, and clinical trial simulation. It also delivers GxP digital empowerment solutions including quality management systems, document management, pharmacovigilance, clinical data capture, and compliant electronic signature systems. The company serves over 300 well-known pharmaceutical and chemical enterprises, collaborates with more than 2000 academic and research institutions, and supports over 100 clinical research institutes and hospitals. With a nationwide service network centered in Shanghai and branches in Beijing, Chongqing, Taipei, and Hong Kong, Tri-I Biotech is recognized for its professional software and high-quality services, holding honors such as ISO9001 and ISO27001 certifications and titles for specialized and innovative enterprises in Shanghai. Its flagship products include the Simcyp Discovery simulator for early drug development decision support, and a broad portfolio of AI-driven platforms for drug discovery, materials design, and clinical research. The company also provides cloud computing services and AI technology services to empower scientific research and compliance in the life sciences industry.